CHARITE-UNIVERSITATSMEDIZIN BERLIN

Patent Owner

Compare Create Portfolio

Stats

Details

Technologies

Intl Class Technology # of Patents/ App Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 18235
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 10157
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9143
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 779
 
 
 
C07K PEPTIDES 7102
 
 
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 5200
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 495
 
 
 
G06F ELECTRIC DIGITAL DATA PROCESSING 3377
 
 
 
A61C DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE 249
 
 
 
C07D HETEROCYCLIC COMPOUNDS 2144

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2014/0228,406 FENTANYL DERIVATIVES AS PH-DEPENDENT OPIOID RECEPTOR AGONISTSAug 17, 12Aug 14, 14[C07D]
2014/0159,725 METHOD AND ARRANGEMENT FOR CHARACTERIZED TISSUE OF HUMAN OR ANIMAL TISSUEApr 20, 12Jun 12, 14[G01R, A61B]
2014/0155,466 USE OF APTAMERS IN THERAPY AND/OR DIAGNOSIS OF AUTOIMMUNE DISEASESMar 02, 12Jun 05, 14[C12N, G01N]
2014/0073,760 USE OF AN ANG-(1-7) RECEPTOR AGONIST IN ACUTE LUNG INJURYJun 28, 13Mar 13, 14[C07D, C07K]
2013/0337,074 USE OF CYTOKINE-RELEASING, BIODEGRADABLE PARTICLES IN HYALURONIC ACID FOR THE TREATMENT OF CARTILAGE DEFECTS, IN PARTICULAR OF OSTEOARTHROSISNov 30, 11Dec 19, 13[A61K]
2013/0302,343 MODULATORS OF IL-12 AND/OR IL-23 FOR THE PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASEJan 04, 12Nov 14, 13[G01N, A61K]
2013/0281,508 MicroRNA target site for cell- or tissue-specific inhibition of expression of a transgeneApr 18, 12Oct 24, 13[C12N, A61P, A61K]
2013/0230,137 X-RAY SYSTEM AND METHOD FOR GENERATING 3D IMAGE DATAApr 21, 11Sep 05, 13[G01N]
2013/0196,285 Device for Infiltration of Approximal Enamel Lesions of TeethMar 11, 13Aug 01, 13[A61C]
2013/0101,624 LINEAR IGE PEPTIDE EPITOPES OF HAZELNUT ALLERGEN COR A 1 AND CELERY ANTIGEN API 1Jul 04, 11Apr 25, 13[C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,795,684 Agent for use in the topical or local treatment of cervical dysplasiasApr 15, 11Aug 05, 14[A61K, C07K]
8,734,154 Device for infiltration of approximal enamel lesions of teethMar 11, 13May 27, 14[A61C]
8,686,063 Method of infiltrating enamel lesionsMay 11, 06Apr 01, 14[A61L, A61K]
8,597,955 HNRNP A3 related peptides and use thereof for diagnosis of rheumatoid arthritisDec 23, 09Dec 03, 13[G01N]
8,501,192 Use of soluble CEACAM8 for diagnosing, treating or monitoring diseases, and a method for screening compounds that prevent apoptosisSep 26, 08Aug 06, 13[A61K]
8,419,427 Device for infiltration of approximal enamel lesions of teethOct 23, 08Apr 16, 13[A61C]
8,404,658 RNA interference for the treatment of heart failureDec 23, 08Mar 26, 13[C12N]
8,383,772 Ang-(1-7) receptor agonistAug 21, 12Feb 26, 13[A61K, C07K]
8,309,091 CEACAM8-related method for treating autoimmune diseasesOct 31, 06Nov 13, 12[A61K, C07K]
8,305,076 Device and method for generating mechanical oscillations in an examination object using magnetic resonance elastographyApr 12, 07Nov 06, 12[G01V]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Filing Date Issue/Pub Date Intl Class
2013/0281,508 MicroRNA target site for cell- or tissue-specific inhibition of expression of a transgeneApr 18, 12Oct 24, 13[C12N, A61P, A61K]
2013/0101,624 LINEAR IGE PEPTIDE EPITOPES OF HAZELNUT ALLERGEN COR A 1 AND CELERY ANTIGEN API 1Jul 04, 11Apr 25, 13[C07K]
2013/0060,005 COMPOSITIONS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN CFTR AND CALNov 05, 12Mar 07, 13[C07K]
2012/0316,428 ARRANGEMENT FOR EXAMINATION AND/OR TREATMENT OF A HUMAN OR ANIMAL BODYDec 15, 10Dec 13, 12[A61B]
2012/0163,689 METHOD AND DEVICE FOR VISUALIZING HUMAN OR ANIMAL BRAIN SEGMENTSDec 28, 10Jun 28, 12[G06K]
2012/0123,192 BED SYSTEM AND A PORTABLE COVER DEVICE FOR A BEDJul 19, 10May 17, 12[A61M, A61G, E04H]
2012/0083,505 Use of opioid receptor antagonists for acute treatment of paraphilic arousal statesJun 08, 10Apr 05, 12[A61P, A61K]
2012/0020,894 Production of Targeted MRI Probes by Biocompatible Coupling of Macromolecules with Charged NanoparticlesAug 07, 08Jan 26, 12[A61K, B82Y]
2011/0313,275 Method and system for providing magnetic resonance imagesJun 18, 10Dec 22, 11[A61B]
2011/0294,894 Pharmaceutical Composition for the Treatment of Solar UrticariaJun 03, 11Dec 01, 11[A61P, A61K]
2011/0281,805 USE OF AN ANG-(1-7) RECEPTOR AGONIST IN ACUTE LUNG INJURYSep 11, 09Nov 17, 11[C07D, A61P, A61K, C07K]
2011/0275,529 IDENTIFICATION AND CHARACTERISATION OF RECOMBINANT VIRAL GENE THERAPY VECTORSSep 21, 09Nov 10, 11[C40B]
2011/0230,737 DEVICE AND METHOD FOR EARLY DIAGNOSIS AND PROGNOSIS OF HEALING PROGRESSIONS, IN PARTICULAR FOR BONE INJURIESOct 01, 09Sep 22, 11[A61B, G01N]
2011/0190,142 DETERMINATION OF RENIN-PRORENIN RECEPTOR ACTIVITYJul 10, 07Aug 04, 11[C07H, C40B, C12Q, G01N, C07K]
2011/0098,374 BONE CEMENT MIXTURE FOR PRODUCING AN MRT-SIGNALING BONE CEMENTFeb 12, 09Apr 28, 11[A61F]
2011/0077,230 COPPER ORGANOCOMPLEXES, USE THEREOF AS ANTITUMOR MEANS AND FOR PROTECTING HEALTHY TISSUE FROM IONIZING RADIATIONFeb 20, 09Mar 31, 11[C07F, A61P, A61K]
2011/0015,133 PAX2 AND PAX8 AS TUMOUR TARGETS FOR IMMUNOLOGIC AND MOLECULAR TREATMENT STRATEGIESAug 20, 07Jan 20, 11[C12N, A61P, G01N, A61K, C07K]
2010/0331,828 HAND-HELD MEDICAL INSTRUMENTOct 31, 08Dec 30, 10[A61B]
2010/0311,809 VIRAL VECTOR SYSTEM, A COMPOSITION COMPRISING THE VIRAL VECTOR SYSTEM AND ITS USEOct 27, 08Dec 09, 10[C12N, A61P, A61K]
2010/0130,856 METHOD AND APPAARATUS FOR THE ELATOGRAPHIC EXAMINATION OF TISSUEMay 07, 08May 27, 10[A61B]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.